Market Cap 263.03M
Revenue (ttm) 0.00
Net Income (ttm) -63.73M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.43
Volume 1,045,200
Avg Vol 639,902
Day's Range N/A - N/A
Shares Out 48.80M
Stochastic %K 68%
Beta 1.71
Analysts Strong Sell
Price Target $16.36

Latest News on ABEO

Pz-Cel Has Massive Potential For RDEB Patients

Apr 21, 2025, 10:00 AM EDT - 4 days ago

Pz-Cel Has Massive Potential For RDEB Patients


US FDA declines to approve Abeona's skin disorder treatment

Apr 22, 2024, 4:31 PM EDT - 1 year ago

US FDA declines to approve Abeona's skin disorder treatment


Abeona Therapeutics Provides Regulatory Update on Pz-cel

Apr 22, 2024, 4:05 PM EDT - 1 year ago

Abeona Therapeutics Provides Regulatory Update on Pz-cel


Abeona Therapeutics Announces $50 Million Credit Facility

Jan 8, 2024, 7:30 AM EST - 1 year ago

Abeona Therapeutics Announces $50 Million Credit Facility


Abeona Therapeutics Joins Rare Disease Company Coalition

Jul 19, 2023, 8:30 AM EDT - 1 year ago

Abeona Therapeutics Joins Rare Disease Company Coalition